{"entity":{"id":"alims-serbia","kind":"institution","name":"Medicines and Medical Devices Agency of Serbia (ALIMS)","aka":["ALIMS","Agencija za lekove i medicinska sredstva Srbije","Agency for Medicines and Medical Devices of Serbia"],"tldr":"Serbia's medicines regulator, founded in 2004. It authorises medicines and clinical trials, and the law gives it an accelerated route, with a 150-day limit, for medicines already authorised through the EU centralised procedure.","summary":"The Medicines and Medical Devices Agency of Serbia was founded on 1 October 2004 under the Law on Medicines and Medical Devices, taking over the assets of the former Institute of Pharmacy of Serbia. It authorises medicines and medical devices, approves clinical trials, controls quality and runs pharmacovigilance. The coordinates are an approximate Belgrade city point.\n\nThe current Law on Medicines and Medical Devices (Official Gazette 30/2010, amended 2012 and 2017) requires the Agency to decide on a complete marketing authorisation application within 210 days, with the clock stopped while it waits for answers. Article 34 provides an accelerated procedure, with a 150-day limit, for a medicine of the highest public health interest, above all a therapeutic innovation, and for a medicine already authorised through the EU centralised procedure; article 35 allows a conditional authorisation for 12 months at a time for serious and life-threatening diseases, rare diseases and centrally authorised medicines. The law treats EU countries and members of the International Council for Harmonisation as having the same or similar authorisation requirements.\n\nIn July 2019 the Agency announced that the World Health Organization had confirmed, after checking 285 indicators in nine areas, that Serbia's national regulatory authority (the Ministry of Health, the Agency and the Batut institute) could be ranked among the 50 best in the world for regulating medicines and vaccines. The announcement does not name a maturity level, and OnCo did not read WHO's own list.","asOf":"2026-11-11","links":[{"label":"ALIMS: about the Agency (Serbian)","url":"https://www.alims.gov.rs/o-agenciji/"},{"label":"Law on Medicines and Medical Devices, articles 28 and 33 to 35 (Serbian, consolidated text, paragraf.rs)","url":"https://www.paragraf.rs/propisi/zakon_o_lekovima_i_medicinskim_sredstvima.html"},{"label":"ALIMS: WHO ranks Serbia among the 50 most developed countries in medicines regulation (30 July 2019, Serbian)","url":"https://www.alims.gov.rs/2019/07/30/%d1%81%d0%b2%d0%b5%d1%82%d1%81%d0%ba%d0%b0-%d0%b7%d0%b4%d1%80%d0%b0%d0%b2%d1%81%d1%82%d0%b2%d0%b5%d0%bd%d0%b0-%d0%be%d1%80%d0%b3%d0%b0%d0%bd%d0%b8%d0%b7%d0%b0%d1%86%d0%b8%d1%98%d0%b0-%d1%81%d0%b2/"},{"label":"ALIMS: register of approved clinical trials","url":"https://www.alims.gov.rs/humani-lekovi/klinicka-ispitivanja/pretraga-klinickih-ispitivanja/"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["serbia-ministry-of-health","batut-institute-of-public-health-serbia"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Belgrade","country":"RS","lat":44.77,"lng":20.48,"institutionType":"government","website":"https://www.alims.gov.rs","programs":["Marketing authorisation of medicines (210 days; accelerated route 150 days)","Accelerated route for medicines authorised by the EU centralised procedure","Conditional authorisation","Clinical trial approval and public register of approved trials","Pharmacovigilance"]},"route":"/institutions/alims-serbia/","neighbours":{"institution":[{"id":"batut-institute-of-public-health-serbia","kind":"institution","name":"Institute of Public Health of Serbia \"Dr Milan Jovanović Batut\"","route":"/institutions/batut-institute-of-public-health-serbia/"},{"id":"serbia-ministry-of-health","kind":"institution","name":"Ministry of Health of the Republic of Serbia","route":"/institutions/serbia-ministry-of-health/"},{"id":"rfzo-serbia","kind":"institution","name":"Republic Health Insurance Fund (RFZO)","route":"/institutions/rfzo-serbia/"}]}}